Skip to main content

University of Leeds Taps Dotmatics Vortex to Support Drug Discovery

Premium

This week, Dotmatics said that the University of Leeds will use its Vortex software to analyze and visualize data for drug discovery research projects.

In a statement, Adam Nelson, a chemical biology professor at the university, said that researchers will use the software to "visualize the properties of large numbers of compounds" and to "prioritize which molecular scaffolds are likely to have most value in drug discovery."

The financial details of the licensing agreement were not disclosed.

Dotmatics' Vortex lets users manipulate data points such as chemical structures; connect data from different sources; and it provides interactive plots, algorithms, and tables that researchers can use to better understand their results.

In addition to the University of Leeds, Dotmatics' software is also helping scientists at the UK's Institute of Cancer Research to develop new treatments for tumors (BI 9/21/2012).

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.